Lilly formalizes genetic discrimination policy

Eli Lilly and Co. said today that it has become the second corporation, after IBM, to make public a policy forbidding using employees’ genetic information to discriminate in employment choices or eligibility for benefits.

The Indianapolis pharmaceutical maker said employees are more likely to take part in individual healthcare programs if they’re assured information from genetic tests won’t be used against them. The announcement formalized an existing practice within Lilly, the company said.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}